Sunshine Biopharma
SBFM
9 hedge funds and large institutions have $142K invested in Sunshine Biopharma in 2025 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 4 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
0.26% less ownership
Funds ownership: 0.5% → 0.23% (-0.26%)
18% less funds holding
Funds holding: 11 → 9 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
58% less capital invested
Capital invested by funds: $337K → $142K (-$196K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$37K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$25.5K |
| 3 |
Morgan Stanley
New York
|
+$17.1K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$2.62K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$83K |
| 2 |
DS
DRW Securities
Chicago,
Illinois
|
-$67K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$38.2K |
| 4 |
Two Sigma Investments
New York
|
-$31.9K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$25.6K |
SBFM Hedge Fund Activity: Q4 2025 in Review
9 of the 8,257 institutional investors tracked by Wall St. Rank reported a position in Sunshine Biopharma (SBFM) for Q4 2025, worth a combined $142K — down 58% from $337K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of SBFM and 2 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 2 added.
The largest buyer was Virtu Financial, opening a new position worth an estimated $37K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $83K sold.
- 9 institutional investors held Sunshine Biopharma (SBFM) as of Q4 2025, down from 11 in Q3 2025.
- Funds reported $142K of Sunshine Biopharma stock for Q4 2025, down 58% quarter-over-quarter.
- 2 funds opened new Sunshine Biopharma positions in Q4 2025 and 4 closed out, a net change of -2 holders.
- The largest Sunshine Biopharma buyer in Q4 2025 was Virtu Financial, an estimated $37K added.
- The largest Sunshine Biopharma seller in Q4 2025 was Renaissance Technologies, an estimated $83K sold.
Based on aggregated 13F filings for Q4 2025.